Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2003

01.08.2003 | Clinical Investigation

Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope

verfasst von: Henrike Wüstemeyer, Andreas Moessner, Cornelia Jahn, Sebastian Wolf

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 8/2003

Einloggen, um Zugang zu erhalten

Abstract

Background

In the industrialized world age-related macular degeneration (ARMD) is the leading cause for legal blindness beyond the age of 65 years. Recent studies indicate that the density of the macular pigment (MP) may play a central role in the development and progression of age-related maculopathy (ARM). We present results of measurements of macular pigment density (MPD) with a modified confocal scanning laser ophthalmoscope and compare macular pigment density values obtained from reflectance and autofluorescence images in healthy subjects.

Methods

A modified confocal scanning laser ophthalmoscope (Heidelberg Engineering, Heidelberg) was optimised for fundus reflectance and autofluorescence images at 488 nm and 514 nm. For autofluorescence imaging a band pass barrier filter with a short wavelength cut off at 530 nm was used. MPD maps were obtained, and MPD was evaluated within two degrees around the foveal center. In this study we included 109 healthy subjects aged from 18–75 years.

Results

Average MPD ranged between 0.16 density units (D.U.) and 0.22 D.U. depending on the techniques used for the measurement. Using the reflectance method the mean MPD was 0.16±0.06 D.U., whereas a MPD of 0.22±0.07 D.U. resulted from autofluorescence images with the 530-nm barrier filter.

Conclusions

This study demonstrates the good feasibility of MPD measurements with a modified confocal SLO. In agreement with previous studies we found higher macular pigment density values calculated from autofluorescence images than from reflectance images. We could not find any differences in MPD related to age and gender. Prospective longitudinal studies to verify the influence of MPD on the development and progression of ARM are needed.
Literatur
1.
Zurück zum Zitat Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age-related macular degeneration. Br J Ophthalmol:867–877 Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age-related macular degeneration. Br J Ophthalmol:867–877
2.
Zurück zum Zitat Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–46PubMed Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–46PubMed
3.
Zurück zum Zitat Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322–3326PubMed Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322–3326PubMed
4.
Zurück zum Zitat Berendschot TT, Willemse-Assink JJM, Bastiaanse M, de Joung PTVM, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928–1932PubMed Berendschot TT, Willemse-Assink JJM, Bastiaanse M, de Joung PTVM, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928–1932PubMed
5.
Zurück zum Zitat Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W (1998) Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci 39:2003–2011PubMed Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W (1998) Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci 39:2003–2011PubMed
6.
Zurück zum Zitat Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PTVM, Klaver CCW, Klein BEK, Klein R, Mitchell P, Sarks JP, Sarks SH, Soubrane G, Taylor HR, Vingerling JR (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39:367–374PubMed Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PTVM, Klaver CCW, Klein BEK, Klein R, Mitchell P, Sarks JP, Sarks SH, Soubrane G, Taylor HR, Vingerling JR (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39:367–374PubMed
7.
Zurück zum Zitat Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by HPLC: retinal distribut age study. Invest Ophthalmol Vis Sci 29:843–849PubMed Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by HPLC: retinal distribut age study. Invest Ophthalmol Vis Sci 29:843–849PubMed
8.
Zurück zum Zitat Bone RA, Landrum JT, Hime GW, Cains A, Zamor J (1993) Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 34:2033–2040PubMed Bone RA, Landrum JT, Hime GW, Cains A, Zamor J (1993) Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 34:2033–2040PubMed
9.
Zurück zum Zitat Bressler NM, Bressler SB (1995) Preventative ophthalmology age-related macular degeneration. Ophthalmology 102:1206–1211PubMed Bressler NM, Bressler SB (1995) Preventative ophthalmology age-related macular degeneration. Ophthalmology 102:1206–1211PubMed
10.
Zurück zum Zitat Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR (1989) The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 107:847–852PubMed Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR (1989) The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 107:847–852PubMed
11.
Zurück zum Zitat Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L (1999) Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l'Age Arch Ophthalmol 117:1384–90 Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L (1999) Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l'Age Arch Ophthalmol 117:1384–90
12.
Zurück zum Zitat Delori FC (1993) Macular pigment density measured by reflectometry and fluorometry. In: Noninvasive assessment of the Visual System. OSA Technical Digest, pp 240–243 Delori FC (1993) Macular pigment density measured by reflectometry and fluorometry. In: Noninvasive assessment of the Visual System. OSA Technical Digest, pp 240–243
13.
Zurück zum Zitat Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opts Socm Am 18:1212–1230 Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opts Socm Am 18:1212–1230
14.
Zurück zum Zitat Hammond BR, Jr., Caruso-Avery M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41:1492–1497PubMed Hammond BR, Jr., Caruso-Avery M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41:1492–1497PubMed
15.
Zurück zum Zitat Holz FG, Pauleikhoff D (1996) Age-related macular degeneration. 2. Therapeutic approaches. Ophthalmologe 93:483–506PubMed Holz FG, Pauleikhoff D (1996) Age-related macular degeneration. 2. Therapeutic approaches. Ophthalmologe 93:483–506PubMed
16.
Zurück zum Zitat Kirchhof B (1997) Surgical aspects of AMD, adjuvant techniques to restore visual function after macular surgery: pigment epithelial transplantation. Opthalmologica Belgica Kirchhof B (1997) Surgical aspects of AMD, adjuvant techniques to restore visual function after macular surgery: pigment epithelial transplantation. Opthalmologica Belgica
17.
Zurück zum Zitat Klein R, Klein BEK, Jensen SC (1997) The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy The beaver dam eye study. Ophthalmology 104:1804–1812PubMed Klein R, Klein BEK, Jensen SC (1997) The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy The beaver dam eye study. Ophthalmology 104:1804–1812PubMed
18.
Zurück zum Zitat Landrum JT, Bone RA (2001) Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 385:28–40PubMed Landrum JT, Bone RA (2001) Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 385:28–40PubMed
19.
Zurück zum Zitat Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: a possible role in protection from age macular degeneration. Adv Pharmacol 38:537–556PubMed Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: a possible role in protection from age macular degeneration. Adv Pharmacol 38:537–556PubMed
20.
Zurück zum Zitat McCarty CA, Mukesh BN, Fu CL (2001) Risk factors for age-related maculopathy. Arch Ophthalmol 119:1455–1462PubMed McCarty CA, Mukesh BN, Fu CL (2001) Risk factors for age-related maculopathy. Arch Ophthalmol 119:1455–1462PubMed
21.
Zurück zum Zitat Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 117:1177–1187PubMed Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 117:1177–1187PubMed
22.
Zurück zum Zitat Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62 [Suppl 6]:1448S–1461S Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62 [Suppl 6]:1448S–1461S
23.
Zurück zum Zitat Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673PubMed Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673PubMed
24.
Zurück zum Zitat Snodderly DM, Handelman GJ, Adler AJ (1991) Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 32:268–279PubMed Snodderly DM, Handelman GJ, Adler AJ (1991) Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 32:268–279PubMed
25.
Zurück zum Zitat The Eye Disease Case Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701–1708PubMed The Eye Disease Case Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701–1708PubMed
26.
Zurück zum Zitat Wooten BR, Hammond BRJ, Land RI, Snodderly DM (1999) A practical method for measuring macular pigment optical. Invest Ophthalmol Vis Sci 40:2481–2489PubMed Wooten BR, Hammond BRJ, Land RI, Snodderly DM (1999) A practical method for measuring macular pigment optical. Invest Ophthalmol Vis Sci 40:2481–2489PubMed
27.
Zurück zum Zitat Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240:666–671PubMed Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240:666–671PubMed
28.
Zurück zum Zitat Young RW (1987) Pathophysiology of age-related macular degeneration. Surv Ophthalmol 31:291PubMed Young RW (1987) Pathophysiology of age-related macular degeneration. Surv Ophthalmol 31:291PubMed
Metadaten
Titel
Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope
verfasst von
Henrike Wüstemeyer
Andreas Moessner
Cornelia Jahn
Sebastian Wolf
Publikationsdatum
01.08.2003
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 8/2003
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-003-0730-9

Weitere Artikel der Ausgabe 8/2003

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2003 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.